Otsuka Canada Pharmaceutical Inc. announces Health Canada approval of TAVNEOS® (avacopan) for ANCA-Associated Vasculitis
Up jobs news,
Health Canada approved the first orally-administered inhibitor of the complement 5a receptor – for the treatment of two types…